Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts

Authors

  • Ante Jelaska MD,

    1. Boston University School of Medicine, and Boston VA Medical Center, Boston, Massachusetts
    2. University of Connecticut Health Center, Farmington, and VA Medical Center, Newington, CT
    Search for more papers by this author
  • Masami Arakawa MD,

    1. University of Connecticut Health Center, Farmington, and VA Medical Center, Newington, CT
    Current affiliation:
    1. Kawasaki Medical School, Okayama, Japan,
    Search for more papers by this author
  • Goran Broketa MD,

    1. University of Connecticut Health Center, Farmington, and VA Medical Center, Newington, CT
    Current affiliation:
    1. State University of New York, Stony Brook
    Search for more papers by this author
  • Joseph H. Korn MD

    Corresponding author
    1. University of Connecticut Health Center, Farmington, and VA Medical Center, Newington, CT
    • The Arthritis Center, Boston University School of Medicine, 80 E. Concord St., Boston, MA, 02118
    Search for more papers by this author

Abstract

Objective. The goal of this study was to quantitatively analyze the distribution of collagen synthesis in normal and systemic sclerosis (SSc) fibroblast populations in order to determine the extent of activation in SSc populations.

Methods. We used quantitative in situ hybridization to assess the population distribution of type I collagen synthesis. Fibroblast cultures were derived from both clinically involved and uninvolved skin regions of patients with SSc, and from healthy adults, and assessed for levels of α1(I) procollagen messenger RNA (mRNA).

Results. Dermal fibroblasts from both patients with SSc and normal adults were heterogeneous for distribution of α1(I) procollagen mRNA when assessed by in situ hybridization, with a wide range of grains per cell. In contrast, clones of neonatal fibroblasts showed a relatively homogeneous distribution of grain counts. Involved SSc skin fibroblasts had a larger proportion of cells in the high collagen-producing mRNA subpopulation (mean ± SEM 28.4 ± 6.85%), compared with normal fibroblasts (1.75 ± 1.44%) and uninvolved fibroblasts (9.6 ± 6.73%). Conversely, within the low collagen-producing mRNA subpopulation, involved fibroblasts had a smaller proportion of cells (mean ± SEM 14.0 ± 5.63%) than did uninvolved fibroblasts (37.8 ± 13.69%), while normal fibroblasts had a majority of the cells in this subpopulation (53.5 ± 8.68%).

Conclusion. These results suggest that only a specific subset of fibroblasts are activated in SSc, as evidenced by an increased proportion of cells with high levels of α1(I) procollagen mRNA. Differences between the SSc and normal fibroblast populations appeared to be quantitative rather than qualitative. This may be a result of either clonal selection or selective activation in the pathogenesis of SSc.

Ancillary